Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05891106 · ClinicalTrials.gov registry record
AONDA Therapeutic Indication Study I
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 55
- Enrollment target
NCT05891106 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 55 participants.
The verdict
NCT05891106 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
This study will be used to support assessment of AIR OPTIX® NIGHT \& DAY® AQUA (AONDA) Soft Contact Lenses' safety and performance in accordance with updated European Union Medical Device Regulation (EU MDR) requirements.
Interventions
- DEVICE Lotrafilcon A contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2023-06-28 |
| Est. Completion | 2023-07-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05891106
The ClinicalTrials.gov registry entry for NCT05891106 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lotrafilcon A contact lenses is the first listed.
NCT05891106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05891106 about?
NCT05891106 is a clinical study titled "AONDA Therapeutic Indication Study I". This study will be used to support assessment of AIR OPTIX® NIGHT \& DAY® AQUA (AONDA) Soft Contact Lenses' safety and performance in accordance with updated European Union Medical Device Regulation (EU MDR) requirements.
What is the current status of trial NCT05891106?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2023-06-28. Estimated completion is 2023-07-10.
What interventions are being tested in trial NCT05891106?
The interventions under investigation include: Lotrafilcon A contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05891106?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.